Nanosonics - Public Comps and Valuation Multiples

Nanosonics Overview

About Nanosonics

Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics’ revenue is made up of capital sales of Trophon units, ongoing consumables sales, and service revenue. By June 2025, there were 37,000 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, over 50% in the US to single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.

Founded

2000

HQ

Employees

470

Website

nanosonics.com.au

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $133M

LTM EBITDA $17.2M

EV

$713M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Nanosonics Financials

As of August 2025, Nanosonics reported last 12-month revenue of $133M and EBITDA of $17.2M.

In the same period, Nanosonics generated $104M in LTM gross profit and $13.4M in net income.

See Nanosonics valuation multiples based on analyst estimates

Nanosonics P&L

In the most recent fiscal year, Nanosonics reported revenue of $130M and EBITDA of $20.9M.

Nanosonics expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Nanosonics valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$133M	XXX	$130M	XXX	XXX	XXX
Gross Profit	$104M	XXX	$102M	XXX	XXX	XXX
Gross Margin	78%	XXX	78%	XXX	XXX	XXX
EBITDA	$17.2M	XXX	$20.9M	XXX	XXX	XXX
EBITDA Margin	13%	XXX	16%	XXX	XXX	XXX
EBIT	$11.7M	XXX	$5.8M	XXX	XXX	XXX
EBIT Margin	9%	XXX	4%	XXX	XXX	XXX
Net Profit	$13.4M	XXX	$13.5M	XXX	XXX	XXX
Net Margin	10%	XXX	10%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Nanosonics including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $133M. EBITDA for the last twelve months was $17.2M. In the most recent fiscal year, Nanosonics achieved $130M in revenue and $20.9M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$133M	Analyst estimates available to subscribers	$130M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$104M	Analyst estimates available to subscribers	$102M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	77.9% gross margin	Analyst estimates available to subscribers	78.2% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$17.2M	Analyst estimates available to subscribers	$20.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	13.0% EBITDA margin	Analyst estimates available to subscribers	16.0% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$11.7M	Analyst estimates available to subscribers	$5.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	8.8% EBIT margin	Analyst estimates available to subscribers	4.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$13.4M	Analyst estimates available to subscribers	$13.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	10.1% net profit margin	Analyst estimates available to subscribers	10.4% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Nanosonics

This financial data table provides comprehensive performance metrics for Nanosonics, a company based in Australia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Nanosonics generated $133M in revenue over the last twelve months.
The company achieved $17.2M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $104M.
Net income over the last twelve months reached $13.4M.

Fiscal Year Performance

In the most recent fiscal year, Nanosonics reported $130M in total revenue.
Fiscal year EBITDA was $20.9M.
The company maintained a gross profit margin of 78.2% in the most recent fiscal year.
EBITDA margin for the fiscal year was 16.0%.
Net profit margin reached 10.4% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Nanosonics. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Nanosonics Stock Performance

Nanosonics has current market cap of AUD 1.2B (or $814M), and EV of AUD 1.1B (or $713M).

Market Cap Evolution

Nanosonics Stock Data

As of September 17, 2025, Nanosonics's stock price is AUD 4 (or $3).

See Nanosonics trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$713M	$814M	XXX	XXX	XXX	XXX	$0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Nanosonics Valuation Multiples

Nanosonics's trades at 5.9x EV/Revenue multiple, and 40.6x EV/EBITDA.

See valuation multiples for Nanosonics and 15K+ public comps

Nanosonics Financial Valuation Multiples

As of September 17, 2025, Nanosonics has market cap of $814M and EV of $713M.

Equity research analysts estimate Nanosonics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Nanosonics has a P/E ratio of 60.5x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$814M	XXX	$814M	XXX	XXX	XXX
EV (current)	$713M	XXX	$713M	XXX	XXX	XXX
EV/Revenue	5.4x	XXX	5.9x	XXX	XXX	XXX
EV/EBITDA	41.4x	XXX	40.6x	XXX	XXX	XXX
EV/EBIT	60.9x	XXX	224.8x	XXX	XXX	XXX
EV/Gross Profit	6.9x	XXX	n/a	XXX	XXX	XXX
P/E	60.5x	XXX	73.8x	XXX	XXX	XXX
EV/FCF	36.8x	XXX	39.2x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Nanosonics Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Nanosonics Margins & Growth Rates

Nanosonics's last 12 month revenue growth is 10%

Nanosonics's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Nanosonics's rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Nanosonics's rule of X is 38% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Nanosonics and other 15K+ public comps

Nanosonics Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	10%	XXX	11%	XXX	XXX	XXX
EBITDA Margin	13%	XXX	14%	XXX	XXX	XXX
EBITDA Growth	13%	XXX	11%	XXX	XXX	XXX
Rule of 40	25%	XXX	25%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	38%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	36%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	17%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	74%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial